Methotrexate (MTX) is the widely agreed upon first-choice second-line agent to treat juvenile idiopathic arthritis (JIA), up to 75% of JIA patients in recent registries have used MTX at some time ...

Biologic therapy reduces TMJ inflammation in children with juvenile arthritis, according to a new study. Findings show ...

Young people with a rare condition called Juvenile Idiopathic Arthritis (JIA) are taking part in clinical research to better ...

Objective: To compare the clinical efficacy of methotrexate and tolerance to the drug in patients with rheumatoid arthritis who were switched from intramuscular to oral administration because of a ...

a key cytokine in rheumatoid arthritis (RA) pathogenesis. Objective: To evaluate through the AMBITION study the efficacy and safety of tocilizumab monotherapy versus methotrexate in patients with ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with ...

EDINA, Minn. — At least one teen has been charged in juvenile court after a planned group attack at a YMCA in Edina left a boy with a traumatic brain injury, according to court documents.